-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Evelo Biosciences, Inc. quarterly/annual Depreciation history and growth rate from 2016 to 2022.
- Evelo Biosciences, Inc. Depreciation for the quarter ending September 30, 2023 was $200K, a 60% decline year-over-year.
- Evelo Biosciences, Inc. Depreciation for the twelve months ending September 30, 2023 was $1.59M, a 24.3% decline year-over-year.
- Evelo Biosciences, Inc. annual Depreciation for 2022 was $2.06M, a 7.04% decline from 2021.
- Evelo Biosciences, Inc. annual Depreciation for 2021 was $2.22M, a 9.38% increase from 2020.
- Evelo Biosciences, Inc. annual Depreciation for 2020 was $2.03M, a 14.9% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)